Hospitalizations in long-term survivors of childhood AML treated with allogeneic HCT-An Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study

Am J Hematol. 2021 Mar 1;96(3):E74-E77. doi: 10.1002/ajh.26071. Epub 2021 Jan 28.

¹ Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
² Department of Pediatrics, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
³ Division of Haematology-Oncology and Stem Cell Transplantation, Children's Hospital, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland.
⁴ Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden.
⁵ Department of Pediatrics, Institution for Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
⁶ Childhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark.
⁷ Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland.
⁸ Department of Pediatrics, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
⁹ Pediatric Oncology and Hematology, Skåne University Hospital, Department of Clinical Sciences, Lund University, Lund, Sweden.
¹⁰ Department of Clinical Medicine, Faculty of Health, Aarhus University and University Hospital, Aarhus, Denmark.
¹¹ Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital Skejby, Aarhus, Denmark.

No abstract available

Publication types